Common Cause Magazine reveals the extensive power of the U.S. pharmaceutical industry; because of the huge amount of money the industry has spent on campaign contributions, lobbyists, and advertising campaigns, any attempt to cap skyrocketing costs or cut subsidies fails in Congress, May 1992.
This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org
